643 related articles for article (PubMed ID: 30106367)
1. ANCA-associated vasculitis in scleroderma: A renal perspective
.
Kant S; Shah AA; Hummers LK; Wigley FM; Geetha D
Clin Nephrol; 2018 Dec; 90(6):413-418. PubMed ID: 30106367
[TBL] [Abstract][Full Text] [Related]
2. [Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis].
Guan N; Yao Y; Yang JY; Xiao HJ; Ding J
Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):283-7. PubMed ID: 23927802
[TBL] [Abstract][Full Text] [Related]
3. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
[TBL] [Abstract][Full Text] [Related]
4. Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement.
Chen Y; Bao H; Liu Z; Zhang H; Zeng C; Liu Z; Hu W
J Nephrol; 2014 Apr; 27(2):159-64. PubMed ID: 24570072
[TBL] [Abstract][Full Text] [Related]
5. Anti-neutrophil antibody associated vasculitis in systemic sclerosis.
Arad U; Balbir-Gurman A; Doenyas-Barak K; Amit-Vazina M; Caspi D; Elkayam O
Semin Arthritis Rheum; 2011 Oct; 41(2):223-9. PubMed ID: 21277620
[TBL] [Abstract][Full Text] [Related]
6. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
[TBL] [Abstract][Full Text] [Related]
7. Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes.
Katikineni VS; Kant S; Gapud EJ; Antiochos B; Manno RL; Phillips M; Seo P; Geetha D
Clin Rheumatol; 2019 Aug; 38(8):2195-2199. PubMed ID: 31037456
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
[TBL] [Abstract][Full Text] [Related]
9. Late restoration of renal function in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation.
Ma TT; Liu YR; Chen M; Zhao MH
Clin Rheumatol; 2018 Aug; 37(8):2143-2150. PubMed ID: 29679168
[TBL] [Abstract][Full Text] [Related]
10. Acute interstitial nephritis caused by ANCA-associated vasculitis: a case based review.
Muhammad A; Xiao Z; Lin W; Zhang Y; Meng T; Ning J; Xu H; Tang R; Xiao X
Clin Rheumatol; 2024 Mar; 43(3):1227-1244. PubMed ID: 37932622
[TBL] [Abstract][Full Text] [Related]
11. Rapidly progressive glomerulonephritis due to systemic lupus erythematosus and ANCA-associated vasculitis overlap.
Farah RI; Shahin NA; Alawneh M; Adwan M
Lupus; 2020 Jul; 29(8):983-986. PubMed ID: 32316845
[TBL] [Abstract][Full Text] [Related]
12. ANCA-Associated Vasculitis: Core Curriculum 2020.
Geetha D; Jefferson JA
Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
[TBL] [Abstract][Full Text] [Related]
13. ANCA-related crescentic glomerulonephritis in systemic sclerosis: revisiting the "normotensive scleroderma renal crisis".
Arnaud L; Huart A; Plaisier E; Francois H; Mougenot B; Tiev K; Kettaneh A; Ronco P; Rougier JP
Clin Nephrol; 2007 Sep; 68(3):165-70. PubMed ID: 17915619
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
[TBL] [Abstract][Full Text] [Related]
15. Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management.
Plumb LA; Oni L; Marks SD; Tullus K
Pediatr Nephrol; 2018 Jan; 33(1):25-39. PubMed ID: 28062909
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
Timlin H; Lee SM; Manno RL; Seo P; Geetha D
Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide followed by rituximab for aggressive multiple-relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
Lionaki S; Fragoulis GE; Venetsanopoulou A; Vlachoyiannopoulos P; Boletis JN; Tzioufas AG
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):155-164. PubMed ID: 28134075
[TBL] [Abstract][Full Text] [Related]
18. ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review.
Wu R; Su J; Zou YR; Zhu J
Eur J Med Res; 2021 Mar; 26(1):30. PubMed ID: 33789719
[TBL] [Abstract][Full Text] [Related]
19. Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis.
Nasr SH; Said SM; Valeri AM; Stokes MB; Masani NN; D'Agati VD; Markowitz GS
Clin J Am Soc Nephrol; 2009 Feb; 4(2):299-308. PubMed ID: 19158367
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
